What is the recommended dosing for furosemide (Lasix)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 1, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Furosemide Recommended Dosing

For most clinical situations, start with furosemide 20-40 mg orally or intravenously as a single dose, with the specific starting dose and route determined by the underlying condition, severity of fluid overload, and prior diuretic exposure. 1, 2, 3

Initial Dosing by Clinical Condition

Heart Failure

  • Acute decompensated heart failure or pulmonary edema: Start with 20-40 mg IV bolus given over 1-2 minutes 1, 2
  • Chronic heart failure with mild edema: Begin with 20-40 mg orally once daily 2, 3
  • For patients already taking >40 mg daily at home who present acutely, start with at least their home dose IV (typically 80 mg) 1
  • Total dose should remain <100 mg in the first 6 hours and <240 mg in the first 24 hours for acute presentations 1, 2

Cirrhosis with Ascites

  • Always start with combination therapy: Furosemide 40 mg + spironolactone 100 mg as a single morning dose 1, 2
  • Maintain the 100:40 spironolactone-to-furosemide ratio when escalating 1, 2
  • Increase both drugs simultaneously every 3-5 days if weight loss is inadequate 1, 2
  • Maximum furosemide dose is 160 mg/day; exceeding this indicates diuretic resistance requiring alternative strategies like large volume paracentesis 1
  • Prefer oral over IV route to avoid acute GFR reduction 1

Nephrotic Syndrome

  • Pediatric patients: Start with 0.5-2 mg/kg per dose IV or orally, up to six times daily (maximum 10 mg/kg/day) 1
  • Administer IV furosemide 0.5-2 mg/kg at the end of albumin infusions when marked hypovolemia or hyponatremia are absent 1
  • High doses (>6 mg/kg/day) should not be given for longer than 1 week 1

Pediatric Dosing (General)

  • Initial dose: 2 mg/kg body weight as a single dose 3
  • May increase by 1-2 mg/kg no sooner than 6-8 hours after previous dose 3
  • Maximum: 6 mg/kg body weight per day 1, 3

Dose Escalation Strategy

When Initial Dose is Inadequate

  • If no response after 6-8 hours: Increase by 20-40 mg increments 1, 3
  • For severe edematous states, doses may be carefully titrated up to 600 mg/day 3
  • Beyond 80-160 mg/day: Consider adding a second diuretic (thiazide or aldosterone antagonist) rather than further escalating furosemide alone 1

Continuous Infusion Alternative

  • After initial bolus, consider continuous infusion at 5-10 mg/hour (maximum rate 4 mg/min) 1
  • This approach may be more effective than repeated boluses in diuretic-resistant patients 4

Critical Pre-Administration Requirements

Do not administer furosemide if any of the following are present: 1, 2

  • Systolic blood pressure <90-100 mmHg (without circulatory support)
  • Marked hypovolemia
  • Severe hyponatremia (serum sodium <120-125 mmol/L)
  • Anuria
  • Severe hypokalemia (<3 mmol/L)

Administration Considerations

Route Selection

  • IV preferred for: Acute situations requiring rapid diuresis, gut edema reducing oral absorption 1
  • Oral preferred for: Cirrhotic patients (better bioavailability, avoids acute GFR reduction), chronic maintenance therapy 1
  • Infusion rate: Doses ≥250 mg must be given over 4 hours to prevent ototoxicity 1

Timing

  • Single morning dose maximizes compliance and reduces nighttime urination 1, 2
  • Peak effect occurs 1-1.5 hours after oral administration, faster with IV 1
  • If twice-daily dosing needed, give second dose at 2 PM (not evening) 1

Monitoring Requirements

Initial Phase (First Week)

  • Urine output: Place bladder catheter in acute settings for hourly monitoring 1
  • Daily weights: Target 0.5 kg/day loss without peripheral edema, 1.0 kg/day with peripheral edema 1
  • Electrolytes: Check sodium, potassium, creatinine every 3-7 days 1
  • Blood pressure: Every 15-30 minutes in first 2 hours after IV administration 1

Ongoing Monitoring

  • Weekly electrolytes after stabilization 1
  • Watch for signs of hypovolemia: decreased skin turgor, hypotension, tachycardia 1

Common Pitfalls to Avoid

  • Never use furosemide to treat or prevent acute kidney injury—only for managing volume overload that complicates AKI 1
  • Do not give to hypotensive patients expecting hemodynamic improvement; it worsens tissue perfusion 1
  • In acute pulmonary edema, do not use as monotherapy—combine with IV nitroglycerin for superior outcomes 1
  • Avoid evening doses—they cause nocturia without improving outcomes 1
  • Do not exceed 160 mg/day in cirrhosis without considering alternative strategies 1

Special Populations

Geriatric Patients

  • Start at the low end of the dosing range (20 mg) 3
  • Titrate cautiously with careful monitoring 3

Renal Impairment

  • Higher doses may be required due to reduced drug delivery to the loop of Henle 1
  • Consider adding a second diuretic rather than escalating beyond 160 mg/day 1

Diuretic Resistance

  • Add thiazide (hydrochlorothiazide 25 mg) or aldosterone antagonist (spironolactone 25-50 mg) 1
  • Consider continuous infusion instead of bolus dosing 1, 4
  • In cirrhosis specifically, proceed to large volume paracentesis rather than exceeding 160 mg/day 1

References

Guideline

Furosemide Administration Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Initial Treatment with Furosemide for Heart, Kidney, or Liver Failure

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.